全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Review of the Inflammatory Chorioretinopathies: The White Dot Syndromes

DOI: 10.1155/2013/783190

Full-Text   Cite this paper   Add to My Lib

Abstract:

The white dot syndromes are a group of inflammatory chorioretinopathies of unknown etiology which have in common a unique and characteristic appearance of multiple yellow-white lesions affecting multiple layers of the retina, retinal pigment epithelium (RPE), choriocapillaris, and the choroid. They also have overlapping clinical features. We discuss acute retinal pigment epitheliopathy, multiple evanescent white dot syndrome, acute posterior multifocal placoid pigment epitheliopathy, multifocal choroiditis and panuveitis, acute zonal occult outer retinopathy, birdshot chorioretinopathy, and serpiginous choroidopathy. Some of these diseases are associated with a viral prodrome suggesting a possible viral/infectious etiology, while others are associated with a number of systemic processes suggesting an autoimmune etiology. We also review the presentation, evaluation/diagnosis, and treatment of these entities as well as the prognosis. Where applicable we discuss recent advancements in diagnosing and treating the white dot syndromes. 1. Introduction White dot syndromes is a term that has come into use over time to describe a group of inflammatory chorioretinopathies, not necessarily related to each other in pathogenesis, management, or prognosis. The common feature is a superficial resemblance of the lesions to each other. Nevertheless, the term conjures in the minds of readers a group of diseases and their unique features. Inflammatory chorioretinopathies, referred to as “white dot syndromes,” are of unknown etiology and typically affect young, healthy adults. Common presenting symptoms include photopsias, blurred vision, floaters, and visual field loss [1]. Many syndromes are characterized by a viral prodrome. The presence of discrete white lesions are located at various levels of the retina, outer retina, RPE, choriocapillaris, and choroid depending on the class of white dot condition [1]. While the etiology of white dot syndromes remains unknown, some suggest an autoimmune/inflammatory cause triggered by an exogenous agent. Some debate that the white dot syndromes are a spectrum of the same disease process, while others debate that each is a separate disease entity [2]. Despite the white dot similarities, most can be distinguished by the natural history, lesion morphology and progression, and fluorescein angiography pattern. 2. Acute Retinal Pigment Epitheliitis (ARPE, Krill Disease) Acute retinal pigment epitheliitis (ARPE) is a unilateral condition that occurs in otherwise healthy young adults in the second to fourth decade. Typically, this benign and

References

[1]  N. E. Abu-Yaghi, S. P. Hartono, D. O. Hodge, J. S. Pulido, and S. J. Bakri, “White dot syndromes: a 20-year study of incidence, clinical features, and outcomes,” Ocular Immunology and Inflammation, vol. 19, no. 6, pp. 426–430, 2011.
[2]  J. Brown Jr., J. C. Folk, C. V. Reddy, and A. E. Kimura, “Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome,” Ophthalmology, vol. 103, no. 7, pp. 1100–1105, 1996.
[3]  A. E. Krill and A. F. Deutman, “Acute retinal pigment epitheliitus,” American Journal of Ophthalmology, vol. 74, no. 2, pp. 193–205, 1972.
[4]  L. M. Jampol, P. A. Sieving, and D. Pugh, “Multiple evanescent white dot syndrome. I. Clinical findings,” Archives of Ophthalmology, vol. 102, no. 5, pp. 671–674, 1984.
[5]  P. A. Sieving, G. A. Fishman, L. M. Jampol, and D. Pugh, “Multiple evanescent white dot syndrome. II. Electrophysiology of the photoreceptors during retinal pigment epithelial disease,” Archives of Ophthalmology, vol. 102, no. 5, pp. 675–679, 1984.
[6]  M. S. Figueroa, E. Ciancas, B. Mompean, and C. Quereda, “Treatment of multiple evanescent white dot syndrome with cyclosporine,” European Journal of Ophthalmology, vol. 11, no. 1, pp. 86–88, 2001.
[7]  R. S. Dhaliwal, A. M. Maguire, R. W. Flower, and N. P. Arribas, “Acute posterior multifocal placoid pigment epitheliopathy: an indocyanine green angiographic study,” Retina, vol. 13, no. 4, pp. 317–325, 1993.
[8]  D. Park, H. Schatz, H. R. McDonald, and R. N. Johnson, “Acute multifocal posterior placoid pigment epitheliopathy: a theory of pathogenesis,” Retina, vol. 15, no. 4, pp. 351–352, 1995.
[9]  H. F. Fine, E. Kim, T. E. Flynn, N. L. Gomes, and S. Chang, “Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccination,” British Journal of Ophthalmology, vol. 94, no. 3, pp. 282–283, 2010.
[10]  E. Mendrinos and E. Baglivo, “Acute posterior multifocal placoid pigment epitheliopathy following influenza vaccination,” Eye, vol. 24, no. 1, pp. 180–181, 2010.
[11]  B. E. Jones, L. M. Jampol, L. A. Yannuzzi et al., “Relentless placoid chorioretinitis: a new entity or an unusual variant of serpiginous chorioretinitis?” Archives of Ophthalmology, vol. 118, no. 7, pp. 931–938, 2000.
[12]  C. A. Wilson, E. A. Choromokos, and R. Sheppard, “Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis,” Archives of Ophthalmology, vol. 106, no. 6, pp. 796–800, 1988.
[13]  R. G. Bryan, K. B. Freund, L. A. Yannuzzi, R. F. Spaide, S. J. Huang, and D. L. Costa, “Multiple evanescent white dot syndrome in patients with multifocal choroiditis,” Retina, vol. 22, no. 3, pp. 317–322, 2002.
[14]  D. A. Quillen, J. B. Davis, J. L. Gottlieb et al., “The white dot syndromes,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 538–550, 2004.
[15]  R. F. Dreyer and J. D. M. Gass, “Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis,” Archives of Ophthalmology, vol. 102, no. 12, pp. 1776–1784, 1984.
[16]  S. K. Vance, S. Khan, J. M. Klancnik, and K. B. Freund, “Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis,” Retina, vol. 31, no. 4, pp. 717–723, 2011.
[17]  M. B. Parodi, P. Iacono, D. S. Kontadakis, I. Zucchiatti, M. L. Cascavilla, and F. Bandello, “Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis,” Archives of Ophthalmology, vol. 128, no. 9, pp. 1100–1103, 2010.
[18]  J. D. M. Gass, “Acute zonal occult outer retinopathy,” Journal of Clinical Neuro-Ophthalmology, vol. 13, no. 2, pp. 79–97, 1993.
[19]  J. D. Gass, A. Agarwal, and I. U. Scott, “Acute zonal occult outer retinopathy: a long-term follow-up study,” American Journal of Ophthalmology, vol. 134, no. 3, pp. 329–339, 2002.
[20]  J. D. Gass, “Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases?” American Journal of Ophthalmology, vol. 135, no. 3, pp. 380–381, 2003.
[21]  K. H. Shah, R. D. Levinson, F. Yu, et al., “Birdshot retinochoroidopathy,” Survey of Ophthalmology, vol. 50, pp. 519–541, 2005.
[22]  R. D. Levinson and C. R. Gonzales, “Birdshot retinochoroidopathy: immunopathogenesis, evaluation, and treatment,” Ophthalmology Clinics of North America, vol. 15, no. 3, pp. 343–350, 2002.
[23]  J. E. Thorne, D. A. Jabs, G. B. Peters, D. Hair, J. P. Dunn, and J. H. Kempen, “Birdshot retinochoroidopathy: ocular complications and visual impairment,” American Journal of Ophthalmology, vol. 140, no. 1, pp. 45.e1–45.e8, 2005.
[24]  H. Koizumi, M. C. Pozzoni, and R. F. Spaide, “Fundus autofluorescence in birdshot chorioretinopathy,” Ophthalmology, vol. 115, no. 5, pp. e15–e20, 2008.
[25]  J. Comander, J. Loewenstein, and L. Sobrin, “Diagnostic testing and disease monitoring in birdshot chorioretinopathy,” Seminars in Ophthalmology, vol. 26, no. 4-5, pp. 329–336, 2011.
[26]  J. J. W. Kuiper, T. Mutis, W. de Jager, J. D. F. de Groot-Mijnes, and A. Rothova, “Intraocular interleukin-17 and proinflammatory cytokines in HLA-A-29-associated birdshot chorioretinopathy,” American Journal of Ophthalmology, vol. 152, no. 2, pp. 177.e1–182.e1, 2011.
[27]  A. T. Vitale, A. Rodriguez, and C. S. Foster, “Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy,” Ophthalmology, vol. 101, no. 5, pp. 822–831, 1994.
[28]  P. Artornsombudh, O. Gevorgyan, A. Payal, et al., “Infliximab treatment of patients with birdshot retinochoroidopathy,” Ophthalmology, vol. 120, no. 3, pp. 588–592, 2013.
[29]  A. Rothova, A. Ossewaarde-van Norel, L. I. Los, and T. T. J. M. Berendschot, “Efficacy of low-dose methotrexate treatment in birdshot chorioretinopathy,” Retina, vol. 31, no. 6, pp. 1150–1155, 2011.
[30]  W.-K. Lim, R. R. Buggage, and R. B. Nussenblatt, “Serpiginous choroiditis,” Survey of Ophthalmology, vol. 50, no. 3, pp. 231–244, 2005.
[31]  L. M. Jampol, D. Orth, M. J. Daily, and M. F. Rabb, “Subretinal neovascularization with geographic (Serpiginous) choroiditis,” American Journal of Ophthalmology, vol. 88, no. 4, pp. 683–689, 1979.
[32]  N. Bouchenaki, L. Cimino, C. Auer, V. T. Tran, and C. P. Herbort, “Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography,” Klinische Monatsblatter fur Augenheilkunde, vol. 219, no. 4, pp. 243–249, 2002.
[33]  K. Balaskas, S. U. Rehman, Y. D’Souza, et al., “Long-term ranibizumaab treatment for choroidal neovascularization secondary to serpiginous choroiditis,” Canadian Journal of Ophthalmology, vol. 47, no. 5, pp. e15–e17, 2012.
[34]  L. M. Jampol and K. G. Becker, “White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease,” American Journal of Ophthalmology, vol. 135, no. 3, pp. 376–379, 2003.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133